It really is his belief. Without going back, I’m recalling this discussion from many years ago. I think we all finally concluded two to three from the first 17 enrolled back in 2008 were still alive past eight years, but ex is right that one passed at 8.5 years, however Ex is stating his belief what happened to the other one or two. Normally, when you live that long, each year out you have less chance of dying of GBM. However, remember most patients were older when diagnosed. So actuarial tables kick in no matter how well one survives GBM.
Anyway, we also all agreed back then that long term survival appeared to improve for later enrolled patients. This could be due to a number of different factors (example, like using more of the available tumor to make lysate), but I’m not going to go into that here.
Market Data 
Markets 
AI
